MSB 12.1% 55.5¢ mesoblast limited

nah, seeing a yes/no to a surrogate endpoint won't break the...

  1. 3,053 Posts.
    lightbulb Created with Sketch. 2
    nah, seeing a yes/no to a surrogate endpoint won't break the blinding. If they'd seen a magnitude of effect or something on the actual (rather than surrogate) endpoints, then that would likely break the blinding.

    To believe that seeing the yes/no would break the blinding is to believe that both MSB and Teva were so incompetent as to design a trial which from the start contained a provision for an early readout that breaks blinding - that's not credible.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
55.5¢
Change
0.060(12.1%)
Mkt cap ! $633.0M
Open High Low Value Volume
50.0¢ 59.0¢ 48.5¢ $16.88M 30.80M

Buyers (Bids)

No. Vol. Price($)
7 99223 55.5¢
 

Sellers (Offers)

Price($) Vol. No.
56.0¢ 44000 4
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
55.5¢
  Change
0.060 ( 15.7 %)
Open High Low Volume
50.5¢ 59.0¢ 48.5¢ 11524458
Last updated 16.02pm 28/03/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.